173 related articles for article (PubMed ID: 32831157)
1. Analysis of the inflammatory tumor microenvironment in meningeal neoplasms.
Berghoff AS; Kresl P; Rajky O; Widhalm G; Ricken G; Hainfellner JA; Marosi C; Birner P; Preusser M
Clin Neuropathol; 2020; 39(6):256-262. PubMed ID: 32831157
[TBL] [Abstract][Full Text] [Related]
2. Association between programmed cell death ligand-1 expression and extracranial metastasis in intracranial solitary fibrous tumor/hemangiopericytoma.
Kamamoto D; Ohara K; Kitamura Y; Yoshida K; Kawakami Y; Sasaki H
J Neurooncol; 2018 Sep; 139(2):251-259. PubMed ID: 29675794
[TBL] [Abstract][Full Text] [Related]
3. Tumor infiltrating lymphocytes and PD-L1 expression in brain metastases of small cell lung cancer (SCLC).
Berghoff AS; Ricken G; Wilhelm D; Rajky O; Widhalm G; Dieckmann K; Birner P; Bartsch R; Preusser M
J Neurooncol; 2016 Oct; 130(1):19-29. PubMed ID: 27436101
[TBL] [Abstract][Full Text] [Related]
4. Tumour infiltrating lymphocyte density differs by meningioma type and is associated with prognosis in atypical meningioma.
Turner CP; McLay J; Hermans IF; Correia J; Bok A; Mehrabi N; Gock S; Highet B; Curtis MA; Dragunow M
Pathology; 2022 Jun; 54(4):417-424. PubMed ID: 35082053
[TBL] [Abstract][Full Text] [Related]
5. Systemic and local immunosuppression in patients with high-grade meningiomas.
Li YD; Veliceasa D; Lamano JB; Lamano JB; Kaur G; Biyashev D; Horbinski CM; Kruser TJ; Bloch O
Cancer Immunol Immunother; 2019 Jun; 68(6):999-1009. PubMed ID: 31030234
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxic T Cells and their Activation Status are Independent Prognostic Markers in Meningiomas.
Rapp C; Dettling S; Liu F; Ull AT; Warta R; Jungk C; Roesch S; Mock A; Sahm F; Schmidt M; Jungwirth G; Zweckberger K; Lamszus K; Gousias K; Kessler AF; Grabe N; Loehr M; Ketter R; Urbschat S; Senft C; Westphal M; Abdollahi A; Debus J; von Deimling A; Unterberg A; Simon M; Herold-Mende CC
Clin Cancer Res; 2019 Sep; 25(17):5260-5270. PubMed ID: 31227506
[TBL] [Abstract][Full Text] [Related]
7. Validation of nuclear STAT6 immunostaining as a diagnostic marker of meningeal solitary fibrous tumor (SFT)/hemangiopericytoma.
Berghoff AS; Kresl P; Bienkowski M; Koelsche C; Rajky U; Hainfellner JA; Preusser M
Clin Neuropathol; 2017; 36 (2017)(2):56-59. PubMed ID: 28128724
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of the immune modulatory molecule PD-L1 (CD274) in anaplastic meningioma.
Du Z; Abedalthagafi M; Aizer AA; McHenry AR; Sun HH; Bray MA; Viramontes O; Machaidze R; Brastianos PK; Reardon DA; Dunn IF; Freeman GJ; Ligon KL; Carpenter AE; Alexander BM; Agar NY; Rodig SJ; Bradshaw EM; Santagata S
Oncotarget; 2015 Mar; 6(7):4704-16. PubMed ID: 25609200
[TBL] [Abstract][Full Text] [Related]
9. A collision tumor of solitary fibrous tumor/hemangiopericytoma and meningioma: A case report with literature review.
Ashizawa K; Ogura K; Nagase S; Sakaguchi A; Tokugawa J; Hishii M; Fukunaga M; Hirose T; Matsumoto T
Pathol Int; 2021 Oct; 71(10):697-706. PubMed ID: 34411369
[TBL] [Abstract][Full Text] [Related]
10. Relationships between tumor microenvironment and clinicopathological parameters in meningioma.
Ding Y; Qiu L; Xu Q; Song L; Yang S; Yang T
Int J Clin Exp Pathol; 2014; 7(10):6973-9. PubMed ID: 25400783
[TBL] [Abstract][Full Text] [Related]
11. PD-L1 expression correlates with tumor-infiltrating lymphocytes and better prognosis in patients with HPV-negative head and neck squamous cell carcinomas.
Sanchez-Canteli M; Granda-Díaz R; Del Rio-Ibisate N; Allonca E; López-Alvarez F; Agorreta J; Garmendia I; Montuenga LM; García-Pedrero JM; Rodrigo JP
Cancer Immunol Immunother; 2020 Oct; 69(10):2089-2100. PubMed ID: 32448984
[TBL] [Abstract][Full Text] [Related]
12. Aberrant expression of thyroid transcription factor-1 in meningeal solitary fibrous tumor/hemangiopericytoma.
Wu H; Du J; Li H; Li Y; Zhang W; Zhou W; Wang W
Brain Tumor Pathol; 2021 Apr; 38(2):122-131. PubMed ID: 33666786
[TBL] [Abstract][Full Text] [Related]
13. Differential Diagnosis of Meningeal SFT-HPC and Meningioma: Which Immunohistochemical Markers Should Be Used?
Macagno N; Figarella-Branger D; Mokthari K; Metellus P; Jouvet A; Vasiljevic A; Loundou A; Bouvier C
Am J Surg Pathol; 2016 Feb; 40(2):270-8. PubMed ID: 26448189
[TBL] [Abstract][Full Text] [Related]
14. Clinical and Radiographic Features for Differentiating Solitary Fibrous Tumor/Hemangiopericytoma From Meningioma.
Ohba S; Murayama K; Nishiyama Y; Adachi K; Yamada S; Abe M; Hasegawa M; Hirose Y
World Neurosurg; 2019 Oct; 130():e383-e392. PubMed ID: 31233926
[TBL] [Abstract][Full Text] [Related]
15. Immune microenvironment in ductal carcinoma in situ: a comparison with invasive carcinoma of the breast.
Kim M; Chung YR; Kim HJ; Woo JW; Ahn S; Park SY
Breast Cancer Res; 2020 Mar; 22(1):32. PubMed ID: 32216826
[TBL] [Abstract][Full Text] [Related]
16. Whole-tumor histogram analysis of apparent diffusion coefficient in differentiating intracranial solitary fibrous tumor/hemangiopericytoma from angiomatous meningioma.
He W; Xiao X; Li X; Guo Y; Guo L; Liu X; Xu Y; Zhou J; Wu Y
Eur J Radiol; 2019 Mar; 112():186-191. PubMed ID: 30777209
[TBL] [Abstract][Full Text] [Related]
17. Expression and prognostic impact of immune modulatory molecule PD-L1 in meningioma.
Han SJ; Reis G; Kohanbash G; Shrivastav S; Magill ST; Molinaro AM; McDermott MW; Theodosopoulos PV; Aghi MK; Berger MS; Butowski NA; Barani I; Phillips JJ; Perry A; Okada H
J Neurooncol; 2016 Dec; 130(3):543-552. PubMed ID: 27624915
[TBL] [Abstract][Full Text] [Related]
18. Integration of tumour infiltrating lymphocytes, programmed cell-death ligand-1, CD8 and FOXP3 in prognostic models for triple-negative breast cancer: Analysis of 244 stage I-III patients treated with standard therapy.
Dieci MV; Tsvetkova V; Griguolo G; Miglietta F; Tasca G; Giorgi CA; Cumerlato E; Massa D; Lo Mele M; Orvieto E; Guarneri V; Conte P
Eur J Cancer; 2020 Sep; 136():7-15. PubMed ID: 32622323
[TBL] [Abstract][Full Text] [Related]
19. Multispectral quantitative immunohistochemical analysis of tumor-infiltrating lymphocytes in relation to programmed death-ligand 1 expression in triple-negative breast cancer.
Sugie T; Sato E; Miyashita M; Yamaguchi R; Sakatani T; Kozuka Y; Moritani S; Suzuki E; Kakimi K; Mikami Y; Moriya T
Breast Cancer; 2020 Jul; 27(4):519-526. PubMed ID: 32447649
[TBL] [Abstract][Full Text] [Related]
20. Spatially Resolved and Quantitative Analysis of the Immunological Landscape in Human Meningiomas.
Yeung J; Yaghoobi V; Aung TN; Vesely MD; Zhang T; Gaule P; Gunel M; Rimm DL; Chen L
J Neuropathol Exp Neurol; 2021 Jan; 80(2):150-159. PubMed ID: 33393633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]